Providing Effective Information to Consumers about Prescription Drug Risks and Benefits; Public WorkshopThe Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), in collaboration with FDA’s Office of the Commissioner (OC), is holding a public workshop on September 24 and 25, 2009 entitled ‘‘Providing Effective Information to Consumers About Prescription Drug Risks and Benefits.’’ This public workshop is intended to explore potential approaches that will result in written prescription drug information for consumers that is comprehensible, accurate, and easy to access.
abrir aquí para acceder al registro:
Providing Effective Information to Consumers about Prescription Drug Risks and Benefits; Public Workshop
No hay comentarios:
Publicar un comentario